Therapies / BioTech / Life Sciences / Biotech / Science / Animals / Biosciences / Clinical / Pharma / Research / National blog main / San Diego / San Diego blog main / San Diego top stories / Amplyx / Boundless Bio / Ciara Kennedy / clinical trials / coronavirus / COVID-19 / Domain Associates / Evercore ISI / Financing / Josh Schimmer / Kim Kamdar / Nancy Hong / RiverVest / startups / VC / Venture Capital / Zach Hornby

How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns

Posted On: Mar 19, 2020   |   Posted By: Xconomy

How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns

Three hundred Takeda employees from the Japanese pharma giant's California research center have been working from home for 10 days straight. Neurocrine Biosciences, one of the few commercial-stage biotechs in town, is working to ensure the animals housed in its vivarium are appropriately minded. Ciara Kennedy, CEO of clinical-stage antifungal therapy developer Amplyx, is facing a slowdown in trial enrollment as hospitals focus on handling the influx of pandemic patients. Local biotech executives and investors shared snapshots of life sciences in the time of coronavirus Wednesday afternoon at Xconomy's Xcelerating Life Sciences San Diego event. The program, originally slated to take...

Continue reading ...